These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 11192282

  • 1. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
    Edeh J, Spalding P.
    J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
    [Abstract] [Full Text] [Related]

  • 2. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
    Grogan L, Tiernan M, Geogeghan N, Smyth B, Keenan E.
    Ir J Med Sci; 2005 Dec; 174(2):14-20. PubMed ID: 16094907
    [Abstract] [Full Text] [Related]

  • 3. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD, Hagan H, Garfein RS, Sabin K, Weinbaum C, Thiede H.
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [Abstract] [Full Text] [Related]

  • 4. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R.
    J Clin Lab Immunol; 1995 May; 47(1):1-9. PubMed ID: 8735431
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A, Young K, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, Puren A, Hausler H.
    BMC Infect Dis; 2020 Sep 07; 20(1):655. PubMed ID: 32894072
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N, Origer A, Couffignal S, Vaillant M, Schmit JC, Lair ML.
    BMC Public Health; 2011 May 19; 11():351. PubMed ID: 21595969
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L.
    Commun Dis Public Health; 2000 Jun 19; 3(2):121-6. PubMed ID: 10902255
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
    Baozhang T, Kaining Z, Jinxing K, Ruchang X, Ming L, Caixia Z, Li T.
    Epidemiol Infect; 1997 Dec 19; 119(3):343-7. PubMed ID: 9440438
    [Abstract] [Full Text] [Related]

  • 12. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM, Gomatos PJ, Rodier GR, Wierzba TF, Darwish A, Khashaba S, Arthur RR.
    Am J Trop Med Hyg; 1996 Aug 19; 55(2):179-84. PubMed ID: 8780457
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Aug 19; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 15. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA, Connell DW, Asgheddi M, Abdullah M, O'Donoghue M, Campbell L, Wickremasinghe MI, Lalvani A, Kon OM, Khan SA.
    World J Gastroenterol; 2015 Aug 07; 21(29):8920-6. PubMed ID: 26269682
    [Abstract] [Full Text] [Related]

  • 16. Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.
    Crofts N, Hopper JL, Milner R, Breschkin AM, Bowden DS, Locarnini SA.
    Eur J Epidemiol; 1994 Dec 07; 10(6):687-94. PubMed ID: 7672048
    [Abstract] [Full Text] [Related]

  • 17. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
    Reekie JM, Levy MH, Richards AH, Wake CJ, Siddall DA, Beasley HM, Kumar S, Butler TG.
    Med J Aust; 2014 Mar 17; 200(5):277-80. PubMed ID: 24641153
    [Abstract] [Full Text] [Related]

  • 18. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G, Hajarizadeh B, Rahmani K, Mohamadi-Bolbanabad A, Darvishi S, Zareie B, Zavareh FA, Sharafi H, Alavian SM, Ramazani R, Eftekhar M, Radfar SR, Piroozi B, Gouya MM.
    Int J Drug Policy; 2019 Nov 17; 73():129-134. PubMed ID: 31654935
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X, He JM, Ding LS, Zhang GQ, Zou XB, Zheng J.
    Arch Virol; 2013 Sep 17; 158(9):1889-94. PubMed ID: 23553454
    [Abstract] [Full Text] [Related]

  • 20. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.
    Stark K, Müller R, Bienzle U, Guggenmoos-Holzmann I.
    AIDS; 1996 Mar 17; 10(3):311-7. PubMed ID: 8882671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.